Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
27981
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Study part: Follow-Up Lymphoma Treatment. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/7/17 12/7/17 -
- 1/1/18 1/1/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 7, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Follow-Up Treatment GOAL Trial B-cell Lymphoma NCT02499003
Follow-Up Treatment GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Follow-Up Treatment GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject ID
Item
Subject-ID
text
C2348585 (UMLS CUI [1])
subsequent lymphoma treatment
Item
Has the patient received any subsequent lymphoma treatment during follow up?
boolean
Number lymphoma treatment
Item
No.
integer
CL Item
2-CDA (1)
CL Item
B-ALL-protocol (2)
CL Item
Bendamustine (3)
CL Item
BM (4)
CL Item
CEMP (5)
CL Item
Chlorambucil (6)
CL Item
CHOEP14 (7)
CL Item
CHOEP21 (8)
CL Item
CHOP14 (9)
CL Item
CHOP21 (10)
CL Item
CVP (11)
CL Item
DexaBEAM (12)
CL Item
DHAP (13)
CL Item
DHOAX (14)
CL Item
Etoposide (15)
CL Item
FC (16)
CL Item
Fludarabine (17)
CL Item
Gemcitabine (18)
CL Item
GemOx (19)
CL Item
ICE (20)
CL Item
IEV (21)
CL Item
IMVP16 (22)
CL Item
Knospe (23)
CL Item
MCP (24)
CL Item
Mega-CHOEP (25)
CL Item
Methotrexat (26)
CL Item
Pixantrone (27)
CL Item
R-DHAC (28)
CL Item
Cyclophosphamide (29)
CL Item
Alemtuzumab (1)
CL Item
lbritumomab (2)
CL Item
Obinutuzumab (3)
CL Item
Ofatumomab (4)
CL Item
Rituximab (5)
CL Item
Bortezomib (1)
CL Item
Everolimus (2)
CL Item
lbrutinib (3)
CL Item
ldelalisib (4)
CL Item
Lenalidomid (5)
CL Item
Temsirolimus (6)
CL Item
Venetoclax (7)
CL Item
BEAM (1)
CL Item
BEAC (2)
CL Item
lbritumomab (3)
CL Item
TBI/Cy (4)
CL Item
Transplant: full allo (5)
CL Item
Transplant: mini allo (6)
CL Item
other conditioning (7)
CL Item
Hd-BM (Carmustin/Melphalan) (8)
Start date
Item
Start date
date
Stop date
Item
Stop date
date
CL Item
CR (1)
CL Item
CRu (2)
CL Item
PR (3)
CL Item
SD (4)
CL Item
PD (5)
CL Item
Discontinued (6)
CL Item
Unknown (7)